Medtronic’s Hugo Surgery Robot Enters European Market
Medtronic’s robotic-assisted surgery system earned a CE mark approval for urologic and gynecologic procedures, which make up about half of all robotic procedures.
You may also be interested in...
Health Canada has licensed Hugo for urologic and gynecologic laparoscopic surgical procedures.
The company originally expected the first-in-human trial of the soft-tissue robotic surgery system to begin in late 2022 and reach the market by 2023, but the company now expects those trials to begin in 2024.
In this final part of a three-part series on the “Future of Surgery” we highlight perspectives of a highly skilled orthopedic robotic surgeon on where we are today in robotic surgery and where we are going, introduce innovative surgical robotics companies, and discuss medtechs’ rising role in robotic surgery.